ISRCTN74588872进行中（未招募）未知
iverpool Experimental Cancer Medicine Centre (LECMC) biomarker discovery programme and prospective sample collection
niversity of Liverpool0 个研究点目标入组 1,500 人开始时间: 2019年12月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •This will vary according to tumour type. In general, the populations will consist of patients undergoing standard diagnosis and treatment for malignancies and premalignant disease in disease areas which are of interest to the LECMC. All patients must, in addition to fulfilling the medical requirements, complete an informed consent procedure including the physical signing of a consent form.
- •Head and Neck:
- •Presumptive or acute diagnosis of head and neck squamous cell cancer (HNSCC) or recognised oral premalignant conditions (OPML) including but not exhaustively oral epithelial dysplasia (OED), proliferative verrucous leucoplakia (PVL), and those individuals who have been treated for these conditions in the past.
- •All patients with suspected or actual diagnosed Pancreatic Ductal Adenocarcinoma (PDAC), and those individuals who are undergoing or have been treated for PDAC in the past.
- •Samples from all patients with histologically and/or cytologically confirmed early, locally advanced or metastatic breast cancer including patients with central nervous system (CNS) involvement defined as metastases to the brain parenchyma, metastases to the leptomeninges and/or paraneoplastic disorders.
- •Added 09/11/2023:
- •Hepatobiliary:
- •All patients with suspected or actual diagnosis of primary or secondary hepatobiliary malignancy.
- •Presumptive, past or actual diagnosis of lung cancer, thymic malignancy or mesothelioma, and those individuals who have been treated for these conditions in the past.
排除标准
- •1. Individuals who are unable to consent
- •2. Under 18 years of age
- •3. Unable to read or translate patient information sheet and/or consent form
研究者
相似试验
招募中
不适用
ational Cancer Center Hospital (NCCH) Phase1 Liquid StudyCancerJPRN-UMIN000047567ational Cancer Center Hospital160
已完成
不适用
Yorkshire Collaborative Small Cell Lung Cancer Studyung (small cell)Small cell lungCancerISRCTN15654915orthern and Yorkshire Clinical Trials and Research Unit (UK)
进行中（未招募）
不适用
AML19 PilotEUCTR2013-000501-22-GBCardiff Univeristy153
招募中
不适用
The Cancer Molecular Screening and Therapeutics (MoST) Program-ScreeningCancer - Any cancerCancerACTRN12616000908437niversity of Sydney7,628
已完成
2 期
Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNCT00167401University of Rochester